BioCatalyst

ferumoxytol, Iron sucrose — catalyst calendar

2 verified catalyst event(s) referencing ferumoxytol, Iron sucrose, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07 (month)
in 9d
ESTIMATED
 READOUT
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA
Phase 3 · Iron Deficiency Anemia
 AMAG Pharmaceuticals, Inc. ferumoxytol, Iron sucrose ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-08-31
in 2mo
ESTIMATED
 READOUT
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmaco
Phase 3 · Chronic Kidney Disease; Iron Deficiency Anemia
 AMAG Pharmaceuticals, Inc. Ferumoxytol, Iron sucrose ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.